2016
DOI: 10.6023/cjoc201511004
|View full text |Cite
|
Sign up to set email alerts
|

Application of Ugi/De-Boc/Cyclization Strategy in the Synthesis of Nitrogen-Containing Heterocycles

Abstract: Ugi/de-Boc/cyclization (UDC) strategy represents a "three-step, one-pot procedure", employing the Ugi multicomponent reaction utilizing one bi-functional group substrates with N-Boc-protected amino, followed by Boc-deprotection and cyclization to synthesize nitrogen-containing heterocycles. This strategy has the characteristics of rapid, efficiency, economy and structural diversity, which can be used to build libraries of complex nitrogen-containing heterocycles and has drawn much attention recently. In this p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2020
2020

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…Dömling and co-workers, 2003 [37] (1 equiv) Ti(OiPr) 4 (1.35 equiv) THF (0.5 M), overnight 12-48 [32][33][34][35][36][37][38][39][40][41][42] Schreiber and co-workers, 2004 [38] (20 mol %) Cu(OTf) 2 ( [23,24] reactions that rely on the ability of organic isocyanides to participate in the nucleophilic attack onto the carbonyl or imine group are among the most studied MCRs. Accordingly, a wide range of post-MCR transformations have been elaborated allowing to upgrade the Passerini and Ugi adducts into potentially bioactive heterocycles [25][26][27][28][29][30][31][32]. While both Passerini and Ugi reactions proved to be quite robust towards different classes of substrates and possess broad functional group tolerance, the difficulties associated with controlling their stereochemical outcome [33][34][35] severely restrict their applicability in medicinal chemistry [36].…”
Section: Asymmetric Protocolmentioning
confidence: 99%
“…Dömling and co-workers, 2003 [37] (1 equiv) Ti(OiPr) 4 (1.35 equiv) THF (0.5 M), overnight 12-48 [32][33][34][35][36][37][38][39][40][41][42] Schreiber and co-workers, 2004 [38] (20 mol %) Cu(OTf) 2 ( [23,24] reactions that rely on the ability of organic isocyanides to participate in the nucleophilic attack onto the carbonyl or imine group are among the most studied MCRs. Accordingly, a wide range of post-MCR transformations have been elaborated allowing to upgrade the Passerini and Ugi adducts into potentially bioactive heterocycles [25][26][27][28][29][30][31][32]. While both Passerini and Ugi reactions proved to be quite robust towards different classes of substrates and possess broad functional group tolerance, the difficulties associated with controlling their stereochemical outcome [33][34][35] severely restrict their applicability in medicinal chemistry [36].…”
Section: Asymmetric Protocolmentioning
confidence: 99%